The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127084801 12708480 1 I 20100825 20131220 20160901 20160901 EXP HK-PFIZER INC-2013366595 PFIZER 78.00 YR F Y 50.00000 KG 20160901 MD HK HK

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127084801 12708480 1 PS IBUPROFEN. IBUPROFEN 1 Oral UNK 18989 TABLET
127084801 12708480 2 SS IBUPROFEN. IBUPROFEN 1 18989 TABLET
127084801 12708480 3 SS CEFUROXIME. CEFUROXIME 1 Oral FREQUENCY : 1 WEEK Y 65483
127084801 12708480 4 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 UNK 0
127084801 12708480 5 C ATORVASTATIN ATORVASTATIN 1 UNK 0
127084801 12708480 6 C DICLOFENAC SODIUM. DICLOFENAC SODIUM 1 UNK 0
127084801 12708480 7 C FAMOTIDINE. FAMOTIDINE 1 UNK 0
127084801 12708480 8 C HYDROXYCHLOROQUINE SULFATE. HYDROXYCHLOROQUINE SULFATE 1 UNK 0
127084801 12708480 9 C MULTIVITAMIN COATED 2 UNK 0
127084801 12708480 10 C NIFEDIPINE. NIFEDIPINE 1 UNK 0
127084801 12708480 11 C SULPHASALAZINE SULFASALAZINE 1 UNK 0
127084801 12708480 12 C CALCIUM CARBONATE. CALCIUM CARBONATE 1 UNK 0
127084801 12708480 13 C HYPROMELLOSE HYPROMELLOSES 1 UNK 0 EYE DROPS
127084801 12708480 14 C ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127084801 12708480 1 Osteoarthritis
127084801 12708480 2 Rheumatoid arthritis
127084801 12708480 3 Urinary tract infection
127084801 12708480 4 Prophylaxis
127084801 12708480 5 Hyperlipidaemia
127084801 12708480 6 Pain
127084801 12708480 7 Gastric disorder
127084801 12708480 8 Rheumatoid arthritis
127084801 12708480 9 Nutritional supplementation
127084801 12708480 10 Hypertension
127084801 12708480 11 Rheumatoid arthritis
127084801 12708480 12 Osteoporosis
127084801 12708480 13 Dry eye
127084801 12708480 14 Osteoporosis

Outcome of event

Event ID CASEID OUTC COD
127084801 12708480 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127084801 12708480 Liver function test abnormal
127084801 12708480 Syncope

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127084801 12708480 1 20091202 20091202 0
127084801 12708480 3 201008 201008 0
127084801 12708480 4 20091202 20091202 0
127084801 12708480 5 20091019 0
127084801 12708480 6 20091204 20110614 0
127084801 12708480 7 20091204 20110614 0
127084801 12708480 8 20100719 0
127084801 12708480 9 20081222 0
127084801 12708480 10 20100719 0
127084801 12708480 11 20090216 20121104 0
127084801 12708480 12 20081222 0
127084801 12708480 13 20000616 0
127084801 12708480 14 20090511 20101209 0